IM Cannabis (IMCC) to Release Quarterly Earnings on Thursday

IM Cannabis (NASDAQ:IMCCGet Free Report) is scheduled to post its quarterly earnings results before the market opens on Thursday, November 14th. Analysts expect IM Cannabis to post earnings of ($1.03) per share for the quarter.

IM Cannabis (NASDAQ:IMCCGet Free Report) last released its earnings results on Wednesday, August 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.84) by $0.67. The business had revenue of $10.78 million during the quarter, compared to analyst estimates of $9.62 million. IM Cannabis had a negative net margin of 26.46% and a negative return on equity of 97.26%. On average, analysts expect IM Cannabis to post $-6 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

IM Cannabis Stock Performance

NASDAQ:IMCC opened at $2.23 on Tuesday. The company has a market cap of $4.98 million, a P/E ratio of -0.58 and a beta of 0.45. IM Cannabis has a twelve month low of $1.13 and a twelve month high of $8.10. The company’s 50-day moving average price is $2.19 and its 200-day moving average price is $2.82. The company has a current ratio of 0.69, a quick ratio of 0.52 and a debt-to-equity ratio of 0.07.

About IM Cannabis

(Get Free Report)

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands.

Featured Articles

Earnings History for IM Cannabis (NASDAQ:IMCC)

Receive News & Ratings for IM Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IM Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.